Despite the fact that inhibitors of mTOR have been employed in the treatment of various dermatologic disorders such as Kaposi sarcoma, tuberous sclerosis, Muir-Torre syndrome, and neurofibromatosis [83], their effects on psoriasis have been investigated only in a small number of case reports [84,86]. Here, MTOR is linked to psoriasis.